Unknown

Dataset Information

0

Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention.


ABSTRACT: Dengue virus and other flaviviruses such as the yellow fever, West Nile, and Japanese encephalitis viruses are emerging vector-borne human pathogens that affect annually more than 100 million individuals and that may cause debilitating and potentially fatal hemorrhagic and encephalitic diseases. Currently, there are no specific antiviral drugs for the treatment of flavivirus-associated disease. A better understanding of the flavivirus-host interactions during the different events of the flaviviral life cycle may be essential when developing novel antiviral strategies. The flaviviral non-structural protein 4b (NS4b) appears to play an important role in flaviviral replication by facilitating the formation of the viral replication complexes and in counteracting innate immune responses such as the following: (i) type I IFN signaling; (ii) RNA interference; (iii) formation of stress granules; and (iv) the unfolded protein response. Intriguingly, NS4b has recently been shown to constitute an excellent target for the selective inhibition of flavivirus replication. We here review the current knowledge on NS4b.

SUBMITTER: Zmurko J 

PROVIDER: S-EPMC4864441 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention.

Zmurko Joanna J   Neyts Johan J   Dallmeier Kai K  

Reviews in medical virology 20150401 4


Dengue virus and other flaviviruses such as the yellow fever, West Nile, and Japanese encephalitis viruses are emerging vector-borne human pathogens that affect annually more than 100 million individuals and that may cause debilitating and potentially fatal hemorrhagic and encephalitic diseases. Currently, there are no specific antiviral drugs for the treatment of flavivirus-associated disease. A better understanding of the flavivirus-host interactions during the different events of the flavivir  ...[more]

Similar Datasets

| S-EPMC3138567 | biostudies-literature
| S-EPMC7712251 | biostudies-literature
| S-EPMC4059200 | biostudies-literature
| S-EPMC6533143 | biostudies-literature
| S-EPMC6003825 | biostudies-literature
| S-EPMC4077717 | biostudies-literature
| S-EPMC4428900 | biostudies-literature
2019-11-14 | PXD011728 | Pride
| S-EPMC2897181 | biostudies-literature
| S-EPMC6086882 | biostudies-literature